Item 2.02 Results of Operations and Financial Condition

On March 24, 2020, T2 Biosystems, Inc. (the "Company") issued a press release announcing preliminary estimated financial results for its fiscal quarter ending March 31, 2020. A copy of the Company's press release is furnished with this report as Exhibit 99.1.

In accordance with General Instruction B.2 of Form 8-K, the information in this Item 2.02 and Exhibit 99.1 of this Current Report on Form 8-K is being furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. Furthermore, such information, including Exhibit 99.1 attached hereto, shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly stated by specific reference in such a filing.

Item 7.01 Regulation FD Disclosure.

On March 24, 2020, the Company issued a press release announcing its entrance into a license agreement with the Center of Discovery and Innovation at Hackensack Meridian Health (the "Center") pursuant to which the Company has licensed the right to adapt the Center's COVID-19 test to run on the Company's T2Dx® Instrument. A copy of the Company's press release is furnished with this report as Exhibit 99.2.

In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01 and Exhibit 99.2 of this Current Report on Form 8-K is being furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. Furthermore, such information, including Exhibit 99.2 attached hereto, shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly stated by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits




(d) Exhibits



Exhibit No.        Description

99.1                 Press Release issued March 24, 2020 announcing preliminary
                   estimated financial results for the quarter ended March 31,
                   2020

99.2                 Press Release issued March 24, 2020 announcing license
                   agreement with Center of Discovery and Innovation at Hackensack
                   Meridian Health

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses